Selective serotonin reuptake inhibitor toxicity: Difference between revisions

m (Rossdonaldson1 moved page SSRI Toxicity to SSRI toxicity)
(Text replacement - "==Treatment==" to "==Management==")
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Most serious adverse effect is potential to produce [[Serotonin Syndrome]]  
*Most serious adverse effect is potential to produce [[Serotonin Syndrome]]  
Line 4: Line 5:


==Clinical Features==
==Clinical Features==
*N/V
*[[Nausea and vomiting]]
*Sedation
*Sedation
*Tremor
*Tremor
*Sinus Tachycardia
*[[Sinus tachycardia]]
*QRS, QT prolongation (citalopram only)
*QRS, [[QT prolongation]] (citalopram only)
*[[Serotonin Syndrome]]
*[[Serotonin syndrome]]


==Treatment==
==Differential Diagnosis==
*[[Serotonin syndrome]]
{{Anticholinergic types}}
 
==Management==
*GI decontamination
*GI decontamination
**Activated charcoal x1
**Activated charcoal x1
Line 20: Line 25:


==See Also==
==See Also==
*[[Serotonin syndrome]]
*[[SNRI Toxicity]]
*[[SNRI Toxicity]]


==Source==
==References==
Tintinalli
<references/>
 


[[Category:Tox]]
[[Category:Toxicology]]

Revision as of 05:54, 9 July 2016

Background

  • Most serious adverse effect is potential to produce Serotonin Syndrome
  • Fatalities are uncommon with pure overdoses

Clinical Features

Differential Diagnosis

Anticholinergic toxicity Causes

Management

  • GI decontamination
    • Activated charcoal x1
    • Gastric lavage unnecessary

Disposition

  • Consider admission for patients who are tachycardic or lethargic 6hr after ingesion

See Also

References

  1. Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium – theory, evidence and practice. Br J Clin Pharmacol. 2015;81(3):516-24.